Table of Contents:

1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 List of Assumptions
2.4 Market Structure
2.5 Key Takeaways
2.6 Key Buying Criteria
3 Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Share Analysis
3.4 Trade Analysis
3.5 Market Pricing Approach
4 Market Impact Analysis
4.1 Porter's Five Force Analysis
4.1.1 Bargaining Power of Buyer
4.1.2 Bargaining Power of Supplier
4.1.3 Threat from substitute
4.1.4 Threat from a New Entrant
4.1.5 Intensity of Competitive Rivalry
4.2 Value Chain Analysis
4.2.1 Device Manufacturers
4.2.2 App Developers
4.2.3 Network providers/ Mobile operators
4.2.4 Healthcare providers and Pharmaceuticals
4.2.5 Patients
4.3 Pricing Analysis
4.3.1 Cost-effectiveness and patients' convenience will drive the home healthcare market
4.4 Investment Opportunity Analysis
4.4.1 Continuous increase in Lifestyle Disease has led to the development of personalized healthcare solutions
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Growing geriatric population
5.2.2 Rising treatment cost and hospital stay
5.2.3 Technological advancements
5.3 Restraints
5.3.1 Patients Safety Concerns
5.4 Opportunities
5.4.1 Rising prevalence of Chronic Disorders
5.4.2 Improvement in Reimbursement Scenario
5.5 Mega Trends
5.5.1 Telemedicine
5.6 Macroeconomic Indicators
5.7 Technology Trends & Assessment
6 Global Home Healthcare Market by Product
6.1 Introduction
6.1.1 Testing, Screening, & Monitoring Products
6.1.2 Therapeutic Products
7 Global Home Healthcare Market by Services
7.1 Introduction
7.1.1 Skilled Nursing Services
7.1.2 Rehabilitation Therapy Services
7.1.3 Unskilled Care Services
7.1.4 Respiratory Therapy Services
7.1.5 Infusion Therapy Services
7.1.6 Pregnancy Care Services
8 Global Home Healthcare Market by Software
8.1 Introduction
8.1.1 Clinical Management Systems
8.1.2 Agency Software
8.1.3 Telehealth Solution
8.1.4 Hospice Solutions
9 Global Home Healthcare Market by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 UK
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Republic of Korea
9.4.5 Australia
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest of Middle East & Africa
10 Company Landscape
10.1 Competitive Landscape
10.2 Company Analysis
10.3 Company Market Share
11 Company Profiles
11.1 Abbott
11.1.1 Financials
11.1.2 Products
11.1.3 Strategy
11.1.4 Key Developments
11.2 GE Healthcare
11.2.1 Financials
11.2.2 Products
11.2.3 Strategy
11.2.4 Key Developments
11.3 Becton Dickinson
11.3.1 Financials
11.3.2 Products
11.3.3 Strategy
11.3.4 Key Developments
11.4 Omron Corporation
11.4.1 Financials
11.4.2 Products
11.4.3 Strategy
11.4.4 Key Developments
11.5 Apple
11.5.1 Financials
11.5.2 Products
11.5.3 Strategy
11.5.4 Key Developments
11.6 Medtronic PLC
11.6.1 Financials
11.6.2 Products
11.6.3 Strategy
11.6.4 Key Developments
11.7 Koninklijke Philips N.V.
11.7.1 Financials
11.7.2 Products
11.7.3 Strategy
11.7.4 Key Developments
11.8 LG Electronics
11.8.1 Financials
11.8.2 Products
11.8.3 Strategy
11.8.4 Key Developments
11.9 Fresenius SE & Co KGaA
11.9.1 Financials
11.9.2 Products
11.9.3 Strategy
11.9.4 Key Developments
11.1 McKesson Corporation
11.10.1 Financials
11.10.2 Products
11.10.3 Strategy
11.10.4 Key Developments
11.11 F. Hoffmann-La Roche AG
11.11.1 Financials
11.11.2 Products
11.11.3 Strategy
11.11.4 Key Developments
11.12 B. Braun Melsungen AG
11.12.1 Financials
11.12.2 Products
11.12.3 Strategy
11.12.4 Key Developments
11.13 3M
11.13.1 Financials
11.13.2 Products
11.13.3 Strategy
11.13.4 Key Developments
11.14 A&D Company
11.14.1 Financials
11.14.2 Products
11.14.3 Strategy
11.14.4 Key Developments
11.15 Kinnser Software
11.15.1 Financials
11.15.2 Products
11.15.3 Strategy
11.15.4 Key Developments
12 Conclusion
12.1 Key Findings
12.1.1 From CEO's View Point
13 Appendix
13.1 Discussion Blue Print